The European Journal of Health Economics

, Volume 18, Issue 4, pp 449–458 | Cite as

Economic impact of patients admitted to stroke units in Spain

  • Jose Alvarez-Sabín
  • Manuel Quintana
  • Jaime Masjuan
  • Juan Oliva-Moreno
  • Javier Mar
  • Nuria Gonzalez-Rojas
  • Virginia Becerra
  • Covadonga Torres
  • María Yebenes
  • CONOCES Investigators Group
Original Paper

Abstract

Objectives

Stroke is a major social and health problem. However, since the recent incorporation of new advances in its management, little is known about the cost of stroke. The aim of this study is to find out the real cost of stroke in Spain.

Methods

This is an epidemiological, observational, prospective, multicenter study of patients diagnosed with stroke and admitted to a stroke unit. Patients were recruited from 16 hospitals throughout Spain and followed up for 1 year. Sociodemographic, clinical, and economic data were collected. Costs (€ 2012) were estimated from the social perspective and were divided into direct healthcare (inpatient, outpatient, and medication), direct non-healthcare (mainly formal and informal care) and labor productivity losses.

Results

A total of 321 patients were included. Mean age was 72.1 years and 176 patients (54.8 %) were male. Total average cost per patient/year was €27,711. Direct healthcare costs amounted to €8491 per patient/year (68.8 % due to inpatient costs) and non-healthcare costs to an average of €18,643 per patient/year (89.5 % due to informal care). Productivity loss costs per patient/year were €276. Total costs of hemorrhagic strokes were slightly higher than ischemic (€28,895 vs. €27,569 per patient/year, p = 0.550) without significant differences. The main variables associated with higher costs were the presence of hypertension (€30,332 vs. €23,234 per patient/year, p < 0.05) and the severity of stroke (p < 0.05), both independently associated after a multivariate analysis.

Conclusions

The cost of patients admitted to stroke units in Spain is €27,711 per patient/year. More than two-thirds are social costs, mainly informal care. Stroke remains a major burden on health systems and society, so additional efforts are needed for its prevention.

Keywords

Cost of illness Economic impact Healthcare and non-healthcare costs Social perspective Stroke 

JEL Classification

I1 (Health) J14 (Economics of the Elderly) 

References

  1. 1.
    Lackland, D.T., Roccella, E.J., Deutsch, A.F., Fornage, M., George, M.G., Howard, G., Kissela, B.M., Kittner, S.J., Lichtman, J.H., Lisabeth, L.D., Schwamm, L.H., Smith, E.E., Towfighi, A.: Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 45, 315–353 (2014)CrossRefPubMedGoogle Scholar
  2. 2.
    Nichols-Larsen, D.S., Clark, P.C., Zeringue, A., Greenspan, A., Blanton, S.: Factors influencing stroke survivor’s quality of life during subacute recovery. Stroke 36, 1480–1484 (2005)CrossRefPubMedGoogle Scholar
  3. 3.
    Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Magid, D., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K., Mohler, E.R., Moy, C.S., Mussolino, M.E., Nichol, G., Paynter, N.P., Schreiner, P.J., Sorlie, P.D., Stein, J., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B.: Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127, e6–e245 (2013)CrossRefPubMedGoogle Scholar
  4. 4.
    Seenan, P., Long, M., Langhorne, P.: Stroke units in their natural habitat: systematic review of observational studies. Stroke 38, 1886–1892 (2007)CrossRefPubMedGoogle Scholar
  5. 5.
    Candelise, L., Gattinoni, M., Bersano, A., Micieli, G., Sterzi, R., Morabito, A.: Stroke-unit care for acute stroke patients: an observational follow-up study. Lancet 369, 299–305 (2007)CrossRefPubMedGoogle Scholar
  6. 6.
    Lees, K.R., Bluhmki, E., Von Kummer, R., Brott, T.G., Toni, D., Grotta, J.C., Albers, G.W., Kaste, M., Marler, J.R., Hamilton, S.A., Tilley, B.C., Davis, S.M., Donnan, G.A., Hacke, W.: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375, 1695–1703 (2010)CrossRefPubMedGoogle Scholar
  7. 7.
    Mar, J., Masjuan, J., Oliva-Moreno, J., Gonzalez-Rojas, N., Becerra, V., Casado, M.A., Torres, C., Yebenes, M., Quintana, M., Alvarez-Sabín, J.: CONOCES Investigators Group: outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain. Health Qual Life Outcomes 13, 230 (2015)CrossRefGoogle Scholar
  8. 8.
    Plan de atención sanitaria al ictus, Alvarez Sabín, j, Alonso De Leciñana, M., Gállego, J., Gil-Peralta, A., Castillo, J., Díez Tejedor, E., Jiménez, C., Gil, A., Lago, C., Martínez-Vila, E., Ortega, A., Rebollo, M., Rubio, F.: Plan de atención sanitaria al ictus. Neurología 21, 717–726 (2006)Google Scholar
  9. 9.
    Masjuan, J., Alvarez-Sabín, J., Arenillas, J., Calleja, S., Castillo, J., Dávalo, A., Díez Tejedor, E., Freijo, M., Gil-Núñez, A., Fernández, J.C., Maestre, J.F., Martínez-Vila, E., Morales, A., Purroy, F., Ramírez, J.M., Segura, T., Serena, J., Tejada, J., Tejero, C.: Plan de asistencia sanitaria al ICTUS II. 2010. Neurología 26, 383–396 (2011)Google Scholar
  10. 10.
    Estrategia en ictus del SNS. Ministerio de Sanidad y Política Social. http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/docs/Estrategia IctusSNS.pdf. (2008). Accessed 21 November 2015
  11. 11.
    Carod-Artal, F.J., Egido-Navarro, J.A., González-Gutiérrez, J.L.: Varela De Seijas, E.: direct cost of cerebrovascular disease during the first year of follow-up. Rev. Neurol. 28, 1123–1130 (1999)PubMedGoogle Scholar
  12. 12.
    Spieler, J.F., Lanoë, J.L., Amarenco, P.: Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc. Dis. 17, 134–142 (2004)CrossRefPubMedGoogle Scholar
  13. 13.
    Beguiristain, J.M., Mar, J.: Arrazola, A: coste de la enfermedad cerebrovascular aguda. Rev. Neurol. 40, 406–411 (2005)PubMedGoogle Scholar
  14. 14.
    Hervás-Angulo, A., Cabasés-Hita, J.M., Forcén-Alonso, T.: Costs deriving from strokes from a social perspective. A retrospective incidence approach with a follow-up at 3 years. Rev. Neurol. 43, 518–525 (2006)PubMedGoogle Scholar
  15. 15.
    Navarrete-Navarro, P., Hart, W.M., López-Bastida, J., Christensen, M.C.: The societal costs of intracerebral hemorrhage in Spain. Eur. J. Neurol. 14, 556–562 (2007)CrossRefPubMedGoogle Scholar
  16. 16.
    López-Bastida, J.: Oliva Moreno, J., Worbes Cerezo, M., Perestelo Pérez, L., Serrano-Aguilar, P., Montón-Álvarez, F.: social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain. BMC Health Serv. Res. 12, 315 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Fattore, G., Torbica, A., Susi, A., Giovanni, A., Benelli, G., Gozzo, M., Toso, V.: The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC Neurol. 12, 137 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Persson, J., Ferraz-Nunes, J., Karlberg, I.: Economic burden of stroke in a large county in Sweden. BMC Health Serv. Res. 12, 341 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Luengo-Fernández, R., Gray, A.M., Rothwell, P.M.: A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke 43, 3343–3351 (2012)CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Mar, J., Alvarez-Sabín, J., Oliva, J., Becerra, V., Casado, M.A., Yébenes, M., González-Rojas, N., Arenillas, J.F., Martínez-Zabaleta, M.T., Rebollo, M., Lago, A., Segura, T., Castillo, J., Gállego, J., Jiménez-Martínez, C., López-Gastón, J.I., Moniche, F., Casado-Naranjo, I., López-Fernández, J.C., González-Rodríguez, C., Escribano, B., Masjuan, J.: Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES. Neurologia 28, 332–339 (2013)Google Scholar
  21. 21.
    Actualización de rentas con el IPC general (sistema IPC base 2011) para periodos anuales completos. http://www.ine.es/calcula/ (2011). Accessed 21 November 2015
  22. 22.
    Spanish Cost Database, e-Salud. Oblikue Consulting. http://www.oblikue. com/bddcostes/Accessed 21 November 2015
  23. 23.
    RECH. Red Española de Costes Hospitalarios. http://www.rechosp.org/rech/ faces/es/jsf/index.jsp. Accessed 21 November 2015
  24. 24.
    Catálogo del Consejo General de Colegios Oficiales de Farmacéuticos. Base de Datos de Medicamentos. https://botplusweb.portalfarma.com. Accessed 21 November 2015
  25. 25.
    Catálogo General de Material Ortoprotésico. Boletín Oficial del País Vasco - lunes 30 de julio de 2007. http://www.lehendakaritza.ejgv. euskadi.net/r48-vacia/es/bopv2/datos/2007/07/0704289a.pdf. (2007). Accessed 21 November 2015
  26. 26.
    Catálogo Hidelasa. HIpermercado DE LA Salud. http://www.hidelasa.com/ esp/index.php. Accessed 21 November 2015
  27. 27.
    Informe del IMSERSO. Las personas mayores en España. Informe 2008. http://www.imserso.es/InterPresent2/groups/imserso/documents/binario/ infppmm2008vol1.pdf. (2008). Accessed 21 November 2015
  28. 28.
    Van Den Berg, B., Brouwer, W.B.F., Koopmanschap, M.A.: Economic valuation of informal care. An overview of methods and applications. Eur. J. Health Econ. 5, 36–45 (2004)CrossRefPubMedGoogle Scholar
  29. 29.
    Evolución del salario mínimo interprofesional por edad, cantidad y periodo. http://www.ine.es/jaxi/tabla.do?path=/t22/a063/a1998/l0/&file=m30026. px&type = pcaxis&L = 0. Accessed 21 November 2015
  30. 30.
    Grossman, M.: The demand for health: a theoretical and empirical investigation. Columbia University Press, Oxford (1972)Google Scholar
  31. 31.
    Diringer, M.N., Edwards, D.F., Mattson, D.T., Atkins, P.T., Sheedy, C.W., Hsu, C.Y., Dromerick, A.W.: Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 30, 724–728 (1999)CrossRefPubMedGoogle Scholar
  32. 32.
    Félix-Redondo, F.J., Consuegra-Sánchez, L., Ramírez-Moreno, J.M., Lozano, L., Escudero, V., Fernández-Bergés, D.: Tendencia de la mortalidad por ictus isquémico (2000-2009) y factores pronóstico. Estudio ICTUS-Extremadura. Rev. Clín. Española 213, 177–185 (2013)CrossRefGoogle Scholar
  33. 33.
    Comas-Herrera, A., Wittenberg, R., Costa-Font, J., Gori, C., Di Maio, A., Patxot, C., Pickard, L., Pozzi, A., Rothgang, H.: Future long-term care expenditure in Germany, Spain, Italy and the United Kingdom. Ageing and society 26, 285–302 (2006)CrossRefGoogle Scholar
  34. 34.
    Economic Policy Committee (2009) European Economy No. 2/2009. 2009 Ageing Report: Economic and budgetary projections for the EU-27 Member States (2008–2060)Google Scholar
  35. 35.
    Assessing Needs of Care in European Nations (ANCIEN project). http://www.ancien-longtermcare.eu/node/27. Accessed 21 November 2015
  36. 36.
    Castillo, J., Vivancos-Mora, J.: Tiempos de llegada al hospital y hasta la atención neurológica de pacientes con ictus agudo. Análisis de un registro multicéntrico nacional: registro EPICES (II). Rev. Neurol. 54, 461–467 (2012)PubMedGoogle Scholar
  37. 37.
    Ministerio de Sanidad, Servicios Sociales e Igualdad. Estrategia Nacional del Ictus 2009. http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/ docs/EstrategiaIctusSNS.pdf. (2009). Accessed 21 November 2015

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Jose Alvarez-Sabín
    • 1
  • Manuel Quintana
    • 1
  • Jaime Masjuan
    • 2
  • Juan Oliva-Moreno
    • 3
  • Javier Mar
    • 4
  • Nuria Gonzalez-Rojas
    • 5
  • Virginia Becerra
    • 5
  • Covadonga Torres
    • 6
  • María Yebenes
    • 6
  • CONOCES Investigators Group
  1. 1.Servei de NeurologiaHospital Universitari Vall d’Hebron, Universitat Autònoma de BarcelonaBarcelonaSpain
  2. 2.Stroke Unit, Department of NeurologyHospital Universitario Ramón y Cajal, Universidad de AlcaláMadridSpain
  3. 3.Department of Economic AnalysisUniversidad de Castilla La Mancha and REDISSECToledoSpain
  4. 4.Clinical Management ServiceHospital Alto DebaMondragonSpain
  5. 5.Health Economics and Outcomes ResearchBoehringer Ingelheim EspañaBarcelonaSpain
  6. 6.Pharmacoeconomics and Outcomes Research IberiaMadridSpain

Personalised recommendations